FDA Investigator Chaoying C Ma
Chaoying C Ma has conducted inspections on 3 sites in 3 countries as of 22 Nov 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
3
Last Inspection Date:
22 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
China,
Israel,
Germany
FDA Investigators that have inspected at least one site in common with Chaoying C Ma:
Azza Talaat,
Bonita S Chester,
Chunsheng Cai, PhD,
Daniel J Lahar,
Dr. Carmelo Rosa,
Dr. Jason R Caballero,
Erika V Butler,
Gavin T Cua,
Ivis L Negron,
Jacob G Lutz,
Joanne Heim,
Joel D Hustedt,
Jose A Lopez,
Lata C Mathew, PhD,
Lori J Silverstein,
Maan S Abduldayem,
Makini Cobourne Duval, PhD,
Margaret M Annes,
Michael A Taylor,
Michele Perry Williams,
Mohsen Rajabi Abhari, FDA,
Mra Munizn,
Muralidhara B Gavini, PhD,
Niketa Patel,
Noreen Muñiz,
Paul L Bellamy,
Peter E Baker,
Peter R Lenahan,
Raymond T Oji,
Robert C Steyert,
Robert J Doyle,
Sam H Haidar, PhD,
Simone E Pitts,
Susan F Laska, MS,
Susanna E Ford,
Taichun Qin, PhD,
Thomas J Arista,
Wei Hua Emily Wu,
Zachary A Bogorad
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more